FDA Approved: QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

The FDA approved a Cipla USA Inc. supplemental application for Quinapril and Hydrochlorothiazide to add the 10/12.5 dosage strength to the product line.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Quinapril and Hydrochlorothiazide (quinapril/hydrochlorothiazide)

Snippet

SUPPL AP for QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5 (QUINAPRIL AND HYDROCHLOROTHIAZIDE 10/12.5)